Your session is about to expire
← Back to Search
MRI-Guided Radiation + Chemotherapy for Rectal Cancer
Study Summary
This trial is testing a new cancer treatment to see if it is safe and works well.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My condition is confirmed rectal adenocarcinoma.I haven't had major surgery in the last 28 days, except for specific minor procedures.I am 18 years old or older.My cancer has not clearly spread to distant parts of my body.My cancer is at an early to mid-stage (I, II, or III).My cancer has spread to distant parts of my body, confirmed by a biopsy or doctor's consensus.I've been cancer-free for 3 years, except for certain skin, breast, or prostate cancers.I've had a recent check-up with weight and vital signs recorded.I have been active and mostly self-sufficient in the last 45 days.I have had radiation in the same area where my current cancer is located.I have had an MRI of the rectum for cancer staging.I can undergo MR scans for my abdomen and pelvis for cancer treatment planning.
- Group 1: Cohort A
- Group 2: Cohort B
- Group 3: Cohort C
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there openings for volunteers in this clinical investigation?
"As indicated in the clinicaltrials.gov registry, this medical trial is currently accepting patients; it was initially listed on June 17th 2021 and underwent its final edit on July 19th 2022."
What is the intended outcome of this medical experiment?
"This clinical trial is primarily assessing the number of subjects in Cohort A with serious adverse events during radiation over an 11.5-week period. Secondary objectives include ascertaining the amount of participants in Cohort B who experience a complete clinical response to treatment, as well as changes from baseline for both Memorial Sloan Kettering Bowel Function Index (MSKCC BFI) Score and Wexner Fecal Incontinence Scores."
Has there been any past experimentation with Introductory Radiation Dosage prior to Increasing the Amount?
"Presently, there are 549 active trials for Initial Dose of Radiation before Dose Escalation worldwide. Of these studies, 190 have progressed to Phase 3 with most being held in Woolloongabba, Queensland. However, overall 20613 locations are running investigations into this therapy."
Has the FDA sanctioned an initial dose of radiation prior to increasing dosage?
"With limited data available to support safety and efficacy, the team at Power assign Initial Dose of Radiation before Dose Escalation a score of 1 on their scale from 1 to 3."
What is the highest number of participants involved in this clinical research?
"Indeed, according to the clinicaltrials.gov page associated with this medical trial, patient recruitment is presently underway. This particular investigation was initially uploaded on June 17th 2021 and later amended on July 19th 2022. The study aims at enrolling 22 individuals from a single location."
What maladies are typically treated with Initial Dose of Radiation before Dose Escalation?
"A Preliminary Radiation Dose before Dosage Increase is often prescribed to treat metastatic colorectal carcinoma, but has also proven effective in treating pancreatic endocrine carcinoma, stage III colon cancer and refractory ovarian cancer."
Share this study with friends
Copy Link
Messenger